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Chagas disease, a zoonosis caused by the flagellate protozoan Trypanosoma cruzi, is
a chronic and systemic parasitic infection that affects ∼5–7 million people worldwide,
mainly in Latin America. Chagas disease is an emerging public health problem due
to the lack of vaccines and effective treatments. According to recent studies, several
T. cruzi secreted proteins interact with the human host during cell invasion. Moreover,
some comparative studies with T. rangeli, which is non-pathogenic in humans, have
been performed to identify proteins directly involved in the pathogenesis of the disease.
In this study, we present an integrated analysis of canonical putative secreted proteins
(PSPs) from both species. Additionally, we propose an interactome with human host
and gene family clusters, and a phylogenetic inference of a selected protein. In total,
we identified 322 exclusively PSPs in T. cruzi and 202 in T. rangeli. Among the PSPs
identified in T. cruzi, we found several trans-sialidases, mucins, MASPs, proteins with
phospholipase 2 domains (PLA2-like), and proteins with Hsp70 domains (Hsp70-like)
which have been previously characterized and demonstrated to be related to T. cruzi
virulence. PSPs found in T. rangeli were related to protozoan metabolism, specifically
carboxylases and phosphatases. Furthermore, we also identified PSPs that may interact
with the human immune system, including heat shock and MASP proteins, but in a lower
number compared to T. cruzi. Interestingly, we describe a hypothetical hybrid interactome
of PSPs which reveals that T. cruzi secreted molecules may be down-regulating IL-17
whilst T. rangeli may enhance the production of IL-15. These results will pave the way
for a better understanding of the pathophysiology of Chagas disease and may ultimately
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lead to the identification of molecular targets, such as key PSPs, that could be used to
minimize the health outcomes of Chagas disease by modulating the immune response
triggered by T. cruzi infection.
Keywords: interactome, secretome, IL17, IL15, Trypanosoma rangeli, Trypanosoma cruzi
INTRODUCTION
Trypanosoma cruzi and Trypanosoma rangeli belong to the genus
Trypanosoma and the family Trypanosomatidae. They are the
only two trypanosomes that infect humans in Latin America (1).
T. rangeli and T. cruzi share the same mammalian hosts and
triatomine vectors in overlapping areas. Although T. rangeli is
non-pathogenic to mammalian hosts, it is harmful to insects. In
particular, it causes morphological abnormalities or even lethal
effects in molting and feeding in the genus Rhodnius (2). It has
been recently reported that T. rangeli is more closely related
to Old World trypanosomes of bats, civets, rats, and monkeys
than to T. cruzi (3). T. cruzi causes Chagas disease, which is
endemic in Latin America. Chagas disease afflicts 6–7 million
individuals worldwide and has been associated with negative
economic impacts in developing countries (4). Approximately
28,000 new cases of Chagas disease are diagnosed and 12,000
deaths are reported every year (4), indicating that Chagas disease
is still a relevant public health issue (5). In addition to these
estimates, demographic and migratory changes have resulted
in the spread of the disease to non-endemic areas in the
American continents, including the United States, and to other
continents (6). T. rangeli shares morphological similarity and
immunological cross-reactivity with T. cruzi, and they can co-
occur as natural mixed infections in both vertebrate hosts and
insect vectors in a broad geographical area (7).
The genome of T. rangeli has been sequenced and compared
to that of T. cruzi (8). It has been shown that T. rangeli contains
a smaller number of gene copies of virulence factors encoded
by multigene families such as the mucin-associated proteins
(MASPs), trans-sialidases (TS), and mucins; and a reduced
repertoire of genes encoding antioxidant enzymes compared to
T. cruzi (8). Additionally, transcriptomic analysis showed that
T. rangeli contains genes encoding factors of virulence and
pathogenicity, such as gp63, sialidases, and oligopeptidases, as
has been described in other kinetoplastids (9). Proteins that
are secreted to the extracellular medium usually contain an N-
terminal signal peptide (SP) that drives them to the classical
endoplasmic reticulum (ER)/Golgi-dependent secretion pathway
[reviewed in Watanabe Costa et al. (10)]. In addition, other
proteins without the canonical SP are secreted via non-classical
pathways, usually through the shedding of extracellular vesicles
(11). A significant amount of data on the genome structure
and expression of human parasitic trypanosomes is currently
available. There have been many studies of the biological
functions of T. cruzi secreted proteins and their role in parasite-
host interactions and pathogenesis [reviewed in Watanabe Costa
et al. (10)].
As it is possible that secreted molecules from trypanosomes
modulate host pathways including the immune response, the
present study focused on species-specific potentially secreted
proteins (PSPs) from T. cruzi and T. rangeli and their interaction
with the host immune response. Using a computational
pipeline which integrates genomic and proteomic data with
bioinformatics predictions, we built an in silico secretome of both
species and identified classically PSPs (i.e., those displaying the
SP without transmembrane domains). Additionally, we built an
interactome and evolution models of a few selected PSPs. This
comparative analysis of T. cruzi and T. rangeli may provide new
insights into how these sympatric species evolved and adapted to
the mammalian host.
MATERIALS AND METHODS
Protein Sequences of Trypanosoma cruzi
and T. rangeli
The protein sequences of T. cruzi (T. cruzi Sylvio X10/1-2012)
used in this study were acquired from the TriTrypDB kinetoplast
database. The protein sequences in FASTA format of T. cruzi was
downloaded in January 14th 2015 and September 20th 2019. The
protein sequence of T. rangeli was provided by the Laboratory of
Bioinformatics of the LNCC—National Laboratory of Scientific
Computing and deposited in TriTrypDB (12) (T. rangeli SC58).
Both sequences contained automatic annotations of proteins.
Prediction and Selection of PSPs
SignalP (version 4.1; default parameters) (13) was used to
predict the presence and location of signal peptide (SP) cleavage
in the amino acid sequence. SecretomeP (version 1.0; default
parameters) (14) was used to perform predictions of secreted
proteins by the non-classical pathway (lacking the canonical
SP). In addition to SignalP, SecretomeP predicts arginine
and lysine cleavage sites in eukaryotic protein sequences and
subcellular localization.
In the case of the parasites studied here, there were some
proteins with a SP, but also with additional transmembrane
regions (which may belong to the cytoplasmic membrane or to
the nuclear membrane, for example). Therefore, the program
TMHMM (version 2.0) (15) was used to perform prediction
of transmembrane helices. HMMTOP (version 2.0) (16, 17),
Tmpred (18), and DAS-Tmfilter (19) were used to validate the
prediction from TMHMM.
This prediction was done by the following steps: (i) generate
fasta files of clean protein sequence (with start metionine and
translated stop codon) with proteins for the individual species,
(ii) run the SignalP and SecretomeP pipelines, (iii) run the
TMHMM program to identify transmembrane proteins, (iv)
validate the TMHMM data with online programs (HMMTOP
2.0, Tmpred, and DAS-TMfilter). The final result included
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only proteins with SP lacking other additional transmembrane
regions. The steps of the pipeline performed are shown in
Supplementary Figure 1.
Annotation of PSPs
The second part of the analysis consisted of evaluating the
results from the protein prediction programs and confirming
them through computational andmanual inspection. In addition,
the Blast2Go (20) (https://www.blast2go.com/) also provided
additional information for proteins noted as hypothetical,
helping the manual inspection.
The BlastGO annotations were based on the similarity levels
of the local file sequences with the QBlast database (21). Mapping
parameters were changed to search results on the non-redundant
reference protein (nr) (21), PSD (21), UniProt (22), Swiss-Prot
(23), TrEMBL (23), RefSeq (24), GenPept (21), and PDB (25).
Assignment of functional terms of the set of GO terms was
assembled in the mapping step. Pie charts were used for showing
the biological functions of T. cruzi and T. rangeli.
In the case of proteins annotated as hypothetical in
TriTrypDB for both species, we used the annotation of the
InterPro (26) and domain entries were characterized if available.
InterPro is embedded in TriTrypDB (https://tritrypdb.org/
tritrypdb/showQuestion.do?questionFullName=GeneQuestions.
GenesByInterproDomain) and once you insert the Gene ID to
search an automatic page opens and the features of the sequence
are shown, including “13. Protein features and properties” where
there is the option of Interpro domains.
Gene Family Comparative Analysis
OrthoMCL (version 1.4) (27–29) (https://orthomcl.org/
orthomcl/?rm=orthomcl) was used to verify which PSPs were
expanded in both species. FASTA sequences of PSPs of T.
cruzi and T. rangeli were used in the comparative analysis. In
summary, OrthoMCL compares all proteins against all protein
sequence similarities and find clusters based on reciprocal
similarities. Protein clusters exhibiting bidirectional similarities
between at least two Trypanosoma species were considered
orthologs and those with bidirectional similarities within each
species were classified as paralogues.
Criteria for Selection of PSPs for
Interactome Analysis
From the OrthoMCL results, some proteins were selected
for both phylogeny and interactome analyses. The following
selection criteria were used: (a) potential modulators of the host
immune system were selected based on the available protein
annotation in the results of Blast2Go similarity annotation
and literature survey of each protein. For the hypothetical or
unknown proteins, conserved domains in other species were
investigated to infer their characterization in NCBI databases,
such as Pfam (European Bioinformatics Institute) (30); (b) some
degree of identity with proteins of the human host. The sequences
were individually verified in the BLAST (nr database) with the
“Organism” field filled withHomo sapiens. The degree of identity
can be visualized in the search result by descending the “Ident”
column. Proteins sharing homology with the human proteins
were considered and those that did not share homology were
withdrawn from the interactome analyzes; (c) annotations not yet
determined in databases. Hypothetical or unknown proteins were
prioritized in the analysis because of the importance of exploiting
the proteins not yet well-documented in the literature. To
obtain some basic data of these proteins as biological functions,
the conserved domains with proteins of other species were
investigated; and (d) proteins found in both species and those
present in only one species. For this criterion, OrthoMCL data
were used to generate a Venn diagram containing proteins of
both species at the intersection with proteins present only in each
species outside the intersection.
These criteria allowed us to elaborate a comparative analysis
between PSPs of T. rangeli and T. cruzi and to identify virulence-
related proteins of T. cruzi, possibly interacting with the human
immune system.
Phylogenetic Inference
T. cruzi phospholipase A2 (PLA2) was selected to perform
phylogeny inference. Sequences were obtained by a search
using MEGABLAST (31) (search for highly similar sequences)
from patatin protein domain from PLA2 (phospholipase 2) of
Trypanosoma cruzi Sylvio strain as query, resulting in a set of
4,354 sequences (Supplementary Table 6).
We obtained multiple sequence alignment by Muscle
algorithm (32), included in the Seaview software (33),
based on 4,354 patatin domain protein sequences of PLA2
(phospholipase 2). Phylogenetic relationships analyses were
made by neighbor-joining (NJ) and Bayesian methods. For NJ
trees the confidence scores of each node were assessed with
bootstrap analysis (34), with 100 replicates. Bayesian inference
was performed using MrBayes 3.2 software (35) based on a
reduced set of PLA2 patatin sequences, a set with 78 sequences
aligned byMuscle (36) withΓ distribution (LG+G) to correct for
rate variation among sites was selected as the substitution model
to Bayesian inference (Supplementary Table 7). Substitution
models were chosen based on the Akaike Information Criterion
(AIC) and Bayesian Information Criterion (BIC), using MEGA
6 software (“find best DNA model” option) (37). Bayesian
consensus tree was constructed with four million generations
with sampling every 100 generations until the standard deviation
from split frequencies were under 0.01. Phylogenetic trees
figure edition was then formatted with the FigTree v1.3.1
software (http://tree.bio.ed.ac.uk/software/figtree/).
Gene and Pathway Network Analysis
The software Ingenuity Pathways Analysis (IPA) (Qiagen,
USA—www.ingenuity.com) was used to build gene and
pathways interaction networks for the parasite PSPs identified
by a screening for orthologous in human protein databases.
Proteins were selected for human interactome according the
criteria cited above (2.5): EKG03115.1 chaperone DNAJ protein,
putative [Trypanosoma cruzi], TCSYLVIO_005847; and two
heat-shock HslVU, ATPase subunit HslU [Trypanosoma rangeli
SC58], TRSC58_01986 and TRSC58_04483 and a 4-nitrophenyl
phosphatase, TRSC58_05352. The list of proteins used in
the analysis were as follows: T. rangelli: XP_011519466.1,
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BAF85005.1, BAF85005.1, NP_006651.2, NP_006651.2,
CAB66856.1, CAB99462.1 and T. cruzi: BAC05229.1,
NP_061072.3, AAO31694.1, NP_005871.1, NP_001530.1,
BAA02656.1, AAB69313.1, EAW58527.1, NP_001123655.1,
NP_057390.1, CAG33377.1, AAK69110.1, EAW85303.1,
AAH31044.2. IPA maintains a graphical database of networks
of interacting genes (Ingenuity Knowledge Base, IKB, Qiagen,
USA-www.ingenuity.com) the analysis performed was based
on the content of date 2019-05. Molecules are represented as
nodes, and the biological relationship between two nodes is
represented as an edge (line). All edges are supported by at
least one reference from the literature, from a textbook, or from
canonical information stored in the IK.
RESULTS AND DISCUSSION
Identification of the Potentially Secreted
Proteins (PSPs) of T. cruzi and T. rangeli
Of the 10,794 predicted protein sequences from the T. cruzi
Sylvio X10/1 genome, 658 sequences were found to contain the
canonical SP and 322 (∼49%) among them did not contain
transmembrane helices according the algorithm TMHMM2.0
(Figure 1A, Supplementary Table 1). These latter sequences
were here categorized as potentially secreted or secretory proteins
(PSPs) that are targeted to the endoplasmic reticulum by the
signal recognition particle (SRP)-receptor pathway. Among 7,448
proteins of the T. rangeli SC58, 492 sequences had the SP
and 202 (41%) of these sequences presented the SP without
transmembrane helices (Figure 1A, Supplementary Table 1).
Comparing the number of PSPs from T. cruzi and T. rangeli,
we observed that the percentage of PSPs was very similar in
both species. Only 3.3 and 2.7% of total protein sequences of
T. cruzi and T. rangeli corresponded to the PSPs, respectively
(Figure 1A). Among the SP-bearing proteins, those containing
transmembrane loops were discarded because they could be
targeted to the membranes of other cell organelles such as
nuclear and mitochondrial membranes or they are cell surface
membrane -spanning proteins. It is noteworthy that among
PSPs (Figure 1A) there are membrane associated proteins by
other post-translational modifications or membrane bound
proteins (38).
Annotations and Biological Functions of
PSPs
Among the PSPs, most proteins of T. cruzi were annotated as
hypothetical followed by a group of T. cruzi multigene families
such as mucin-associated surface proteins (MASP), mucin
(TcMUCII), trans-sialidases and trans-sialidases-like (TS), RHS,
gp63 surface protease, and DGF-1 (Supplementary Table 2,
Supplementary Figure 2). Single copy genes code most of
hypothetical proteins classified as PSPs in T. cruzi, whereas few
PSPs (e.g., TCSYLVIO_011009; TCSYLVIO_008005) belong to
small gene families (15–30 members). Other proteins were found
in a smaller number in the analysis (Supplementary Table 2,
Supplementary Figure 2). Finally, the main biological functions
related to the T. cruzi PSPs were cellular, metabolic and
single-organism processes (Figure 1B, and to detailed functional
categories of PSPs see Supplementary Table 2).
Concerning T. rangeli PSPs, cellular and metabolic
processes are the main biological functions (Figure 1C,
Supplementary Figure 2, and to detailed functional categories of
PSPs see Supplementary Table 3). Other proteins were involved
in regulation of biological processes, such as response to stimuli,
location, and organization of cellular components and biogenesis
(Figure 1C, and to detailed functional categories of PSPs see
Supplementary Table 3).
Comparative Analysis of OrthoMCL Cluster
Composition
Using OrthoMCL software, protein clusters (families) were
identified for T. cruzi and T. rangeli. A total of 123 PSPs were
present only in T. cruzi, 49 proteins were shared by both species,
and 13 proteins were found only in T. rangeli (Figure 1D,
Table 1, Supplementary Table 4).
In comparison to T. rangeli, we observed a higher number of
genes belonging to multigene families in T. cruzi, such as mucins
(TcMUCII), MASPs, and TS/TS-like proteins (39–47) (Table 1,
Supplementary Table 4); and dispersed gene family protein 1
(DGF-1) (40, 48–52), gp63 (40, 53–56), and gp90, a putative 90
kDa surface protein which was renamed SAP (Serine, Alanine,
and Proline-rich protein) (57, 58). Stoco et al. (8) demonstrated
that the T. rangeli genome contains a smaller number of sequence
copies from MASP, mucin, and TS/TS like proteins compared
to the T. cruzi genome (8), which is consistent with our PSP
findings. All these proteins have been reported to participate in
the host invasion process, including virulence and pathogenicity.
TheMASP family is the second largest T. cruzi family of proteins,
representing ∼6% of the parasite genome (40, 41). MASPs may
be involved in lymphocyte activation, promoting polyclonal
expansion, and hypergammaglobulinemia, which delays the
specific humoral response characteristic of the acute phase of
Chagas disease. B cell activation promotes the immune response,
preventing the specific response from occurring, preventing
parasite neutralization and elimination (59–62). Studies have
shown that TS/TS-like proteins are virulence factors, as they
are involved in the adhesion of T. cruzi to the host cell,
internalization, and intracellular survival [reviewed in (63)]. T.
cruzi mucins (TcMUCII) found in the present study are present
on the parasite surface and have two main functions: (i) provide
protection against vector and host defense mechanisms and (ii)
ensure the target for invasion into specific cells or tissues (43, 64–
67). Some studies have reported that the gp63 glycoproteins
identified by this study have the ability to inactivate the host
complement system, facilitating the invasion and survival of
T. cruzi (54–56, 68). SAP binds to the host cell and induces
intracellular Ca2+ mobilization and host cell lysosome exocytosis
(57, 58).
Among the hypothetical proteins, we identified a domain
from heat shock protein 70 (Hsp70) which is presented in both
species (Supplementary Table 1, green lines). Hsp70 interacts
with cells of the immune system, exerting immunoregulatory
effects. Exogenously added Hsp70 has potent cytokine activity
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FIGURE 1 | Identification of the potentially secreted proteins (PSPs) of T. cruzi and T. rangeli. (A) Trypanosome species analyzed. Number of total protein sequences,
amount of protein sequences with signal peptide [SIGNAL PEPTIDE (+)] and without transmembrane domains [TRANSMEMBRANE (-)]. Percentage of PSPs identified
from the genome of each species; (B) Biological processes of the T. cruzi PSPs found by the Blast2Go program. The numbers given in parentheses show the amount
of proteins related to a given biological function; (C) Biological processes of the T. rangeli PSPs found by the Blast2Go program. The numbers given in parentheses
show the amount of proteins related to a given biological function; (D) Quantitative analysis by OrthoMCL. Amount of grouped proteins found in each organism and in
both species.
and binds with high affinity to the plasma membrane, triggering
rapid intracellular Ca2+ flow, activating nuclear factor kβ
(NF-kβ), and positively regulating proinflammatory cytokine
expression in human monocytes (69). From a diagnostic point
of view, although anti-Hsp antibodies are unable to distinguish
chagasic patients from those infected with other trypanosomes,
T. cruzi anti-Hsp70 antibodies can distinguish between healthy
and infected patients and between those in the acute phase and
those in the chronic phase (70, 71). These results, in combination
with the findings of our study, corroborate the importance of
studying T. cruzi secreted proteins.
Several PSPs were found in both species, including gp63
surface proteases, glucose-regulated proteins, serine/threonine
phosphatases, methyltransferases, DNA ligases, cytochrome
b5 reductase, acetyltransferases, and others (Table 1,
Supplementary Tables 1, 4). These proteins are related to
cellular processes, replication, and metabolism. Among these
proteins, only gp63 has been described in previous studies
as being related to T. cruzi infection in host cells. Gp63
is differentially expressed in specific stages of the parasite
cycle and is more highly expressed in amastigotes than in
epimastigotes or trypomastigotes (72). Previous genomic studies
have demonstrated that despite the non-pathogenic nature of
T. rangeli in mammals, several secreted, and surface protein
genes associated with virulence and pathogenicity in other
pathogenic trypanosomatids, such as gp63, are present in T.
rangeli (8, 73) (Table 1, Supplementary Tables 1, 4). Finally,
in the group of protein families found only in T. rangeli, some
hypothetical proteins were grouped with domains in MASPs,
WD40, and phosphoenolpyruvate carboxylase, in addition
to phosphatases and heat shock proteins HsIVU (Table 1,
Supplementary Table 4).
Interestingly, some SP-displaying proteins already described
to be secreted in the CL Brener clone, such as cruzipain
(TcCLB.507603.270, major cysteine proteinase, putative,
Esmeraldo-like; TcCLB.507603.260, cysteine peptidase, putative,
Esmeraldo-like), P21 (TcCLB.509767.140, Esmeraldo-like)
[both reviewed in Watanabe Costa et al. (10)], and mevalonate
kinase (TcCLB.436521.9, Esmeraldo-like) (74, 75) were not
found among the PSPs in the Sylvio clone (X10/1-2012)
secretome (Supplementary Table 1). A similarity search (BLAST
software) using tags of CL Brener in TriTrypDB did not find
similar molecules exhibiting SPs in T. cruzi Sylvio (X10/1-
2012). However, phospholipase and cyclophilin (10) do appear
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TABLE 1 | Qualitative data of protein families found by OrthoMCL (full table in Supplementary Table 4).
Trypanosoma cruzi Sylvio Both species Trypanosoma rangeli
Trans-sialidase Surface protease GP63/Leishmanolysin Heat shock protein HslVU, ATPase subunit
HslU
Mucin TcMUCII Glucose-regulated protein 78 4-nitrophenyl phosphatase
Retrotransposon hot spot Serine/threonine protein phosphatase *HP: mucin-associated surface protein (MASP)
Mucin-associated surface protein (MASP) Methyltransferase *HP: phosphoenolpyruvate carboxykinase
Dispersed gene family protein 1 (DGF-1) DNA ligase *HP: WD40 domain
90 kDa surface protein Cytochrome-b5 reductase Hypothetical protein
Surface protease GP63 Legume-like lectin
Lipase NADH-cytochrome b5 reductase
Protein disulfide isomerase RNA editing complex protein MP46
Aldehyde dehydrogenase ATP-dependent DEAD/H RNA helicase
UDP-Gal or UDP-GlcNAc- dependent glycosyltransferase Dihydrolipoamide acetyltransferase
Surface protein ToIT Acid phosphatase
Heat shock protein DNAJ Cyclophilin
Hypothetical protein *HP: DNA-binding transcriptional activator domain
*HP: NAD(P)-binding domain
FAD-dependente oxidoreductase domain




in T. cruzi Sylvio (X10/1-2012) secretome searches. These
differences may be due to the high polymorphism among T
cruzi strains from different lineages (CL Brener- lineage TcVI
and Sylvio X10/1-lineage TcI), which is likely reflected in their
infectivity modeling in different hosts, pathology evolution, and
clinical manifestations (76). Conversely, a biological secretome
(77) of T. cruzi CL Brener showed that many proteins found
using our in silico strategy are also found in the biological
secretome, such as protein kinases, lipases, heat shock proteins,
DNA repair proteins, superoxide dismutase, transialidases,
gp63, mucins, MASPs, and DGF-1. This indicates that in silico
strategies are useful in selecting PSPs before proceeding to
subsequent biological studies.
To find orthologs for PSPs in other isolates of T. cruzi
we performed a manual search with BLASTP using a
sample of 186 PSPs of Sylvio X10/1 as query against the
genomes of clones Dm28 (TcI), CL Brener (TcVI, Esmeraldo-
like, and non-Esmeraldo-like haplotypes) and TCC (TcVI)
deposited in TriTrypDB (Supplementary Table 5). One
hundred and three orthologous (55.4%) found in these
isolates can be classified as PSP according our criteria. They
are distributed as follows, 45 PSPs (24.2%) were found in
the three isolates, whereas 58 PSPs (31.2%) were found in
one or two isolates. Eighty-three proteins (44.6%) could
not be classified in any of the three isolates. The variability
regarding the presence of SP can be noticed when comparing
the PSPs of T. cruzi Sylvio X10/1 (TcI) by BLAST with
orthologs of other strains from the same TcI lineage, such
as Dm28, or clones CL Brener e TCC from a different
lineage (TcVI).
Characteristics of Proteins Selected for
Phylogeny and Interactome Analyzes
After OrthoMCL analysis, some proteins have been selected
to perform both phylogeny inference and interactome analyzes
(see Materials and Methods: 2.5. Criteria for selection of PSPs
for interactome analysis), taking into account that the proteins
selected must indicate implications in the modulation of host
immune system.
TCSYLVIO_003749 (Supplementary Table 1, yellow line),
annotated as a hypothetical protein, was selected only for
phylogeny, because it did not have any similarity to human
proteins to perform interactome analysis. It is a hypothetical PSP
with a phospholipase 2 (PLA2) domain found in T. cruzi Sylvio.
This protein was also found in T. cruzi CL Brener, exhibiting a
SP but no transmembrane regions (TcCLB.506705.40). Although
this protein did not meet protein filter criteria “b” (see Materials
and Methods: Criteria for selection of PSPs for interactome
analysis) previous studies have shown a relationship between
T. cruzi phospholipases and parasite invasion and survival
in the host (78, 79). In T. rangeli, the orthologous protein
(TRSC58_01394) has transmembrane regions, thus it was not
included in the secretome list. It is a hypothetical triacylglycerol
lipase 3 (TGL3) carrying the conserved protein domains of
superfamilies DUF 3336, patatin, and phospholipase A2 (PLA2).
This is referred to as PLA2-like in later analyses. TGL3 is
reported to be responsible for triacylglycerol lipase activity in
the lipid particle. Patatin is a family consisting of several plant
glycoproteins (80). The phospholipases present in T. cruzi could
be related to host immune evasion mechanisms. It has been
shown in Vero cells that phospholipase A1 is involved in cellular
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lipid modifications leading to protein kinase C (PKC) activation.
With PKC activation, Ca2+ release occurs from intracellular
stocks, contributing to parasite invasion (79).
DNAJ (TCSYLVIO_005847) (Table 1, Supplementary
Table 1, blue lines, Supplementary Table 4), was found to be
a PSP only in T. cruzi and was selected to build a hypothetical
hybrid interactome, as it has homology with human proteins.
T. cruzi DNAJ (or Hsp40) protein, acts as a Hsp70 chaperone
forming a protein folding pathway that integrates with Hsp90.
Several environmental stimuli acting upon the parasite during
evolutionary selection have resulted in a very expanded and
varied chaperone network. Heat shock protein expression is
increased during the transition of the parasite from the vector
insect (temperature ∼ 26◦C) to the human host (∼ 37–38◦C),
during which there is differentiation from trypomastigotes
to amastigotes. Heat shock proteins are also involved with
pathogenesis in the host. For example, Hsp90, paralleling the
human interactome proteins HSP90AB1 and HSP90AA1, may
be involved in the development and intracellular growth of
the parasite and represents a potential target for therapeutic
interventions (81–84). Real et al. (85) demonstrated that
Leishmania (L.) amazonensis (trypanosomatid that causes
Leishmaniasis) secretes an ortholog to mouse Hsp70 kDa protein
5 (HSPA5) (69% identity; 90% sequence coverage). Considering
that parasite factors mimic their mammalian counterparts, a
hypothetical Leishmania-mouse interactome was proposed to
identify host components that could be affected by the secretion
of Leishmania HSPA5. The model predicted an interaction
between an L. amazonensis HSPA5 and mammalian Toll-like
receptor 9, which is implicated in important immune responses
such as cytokine and nitric oxide production (85).
We selected three proteins found only in T. rangeli
by OrthoMCL (Table 1, Supplementary Table 1, blue
lines, Supplementary Table 4) that share homology with
human proteins: two heat shock HsIVU (TRSC58_01986
and TRSC58_04483) and a 4-nitrophenyl phosphatase,
TRSC58_05352. They are present in several strains of T.
cruzi (e.g., CL Brener), but they do not have SPs as they do in
T. rangeli. According to BLAST, proteins TRSC58_01986 and
TRSC58_04483 (heat shock domain HsIVU) have homology
with some human proteins, such as ATPases and ATP-dependent
metalloproteinases, and TRSC58_05352 (4-nitrophenyl
phosphatase) has homology to some human phosphatases.
PLA2, a Possible Immune Modulator, Has a
Plant Phospholipase Domain Which Has
Not Been Acquired by Horizontal Transfer
Phospholipases are involved in multiple physiological processes,
including the generation of lipid signaling. Tc-PLA1, T. cruzi
phospholipase A1, is secreted into the extracellular medium
during the infective stages (amastigotes and trypomastigotes). It
displays high membrane binding activity and may be involved in
parasite-host interaction events prior to cellular invasion (78, 79).
Interestingly, Tc-PLA1 does not display a SP in the Sylvio strain,
but does in the CL Brener strain. We then chose the hypothetical
protein PLA2, another phospholipase, to generate a phylogenetic
tree because of a potential function in modulating host immune
mechanisms and parasite invasion due to a similar function in
PLA1 and the existence of a Patatin-like domain in its sequence.
Patatin is a family of glycoproteins that accounts for up to
40% of the total soluble protein in potato tubers (86). When
we performed a BLAST search with PLA2-like of T. cruzi
(TCSYLVIO_003749), many plant species sequences with some
similarity to the Patatin domain were retrieved (not shown).
Because of this, we questioned whether the Patatin domain in
the PLA2-like gene had been acquired by horizontal transfer
(HTG). We have reported an HTG event of a FYVE domain
present only in viruses, such as Acanthamoeba mimivirus,
transferred to phosphatidylinositol kinases (PIK) of T. brucei,
Leishmania, and T. cruzi (87). The FYVE-PIK architecture
is only present in trypanosomatids and viruses, suggesting a
horizontal acquisition hypothesis that was supported by Bayesian
phylogenetic inference (87). An HTG event has also been
demonstrated for some Trypanosoma species in which they
acquired Proline-racemase (PRAC) genes, previously identified
in a restricted group of bacteria. The PRAC genes act as virulence
factors in the highly pathogenic bacteria Clostridium difficile and
Pseudomonas aeruginosa (88).
Thus, to test the hypothesis of PLA2-like patatin domain
HGT, we generated a phylogenetic gene tree based on PLA2-
like amino acid sequences. While, “gene trees” represent the
evolutionary history of the genes studied and can be incongruent
with species trees, “species trees” are usually constructed with
orthologous genes, aiming to recover the genealogy of taxa
(89). The reason for the incongruence can be: (1) differences
in rates of evolution, (2) occurrence of gene loss and/or gene
duplication, (3) recombination between neighboring regions,
and (4) horizontal gene transfer (HGT) (90). The use of
phylogeny can indicate HGT events by revealing incompatibility
between the gene and species evolutionary histories exposed
by reconstruction of the phylogenetic gene and species trees,
using the species tree as a reference (89). Differences between
gene trees and species trees can be suggestive of HGT events.
Gene trees can provide evidence for genetic processes as well
as HGT. If two species are connected in the same branch
of a gene tree but are evolutionarily distant according to the
species tree, a HGT event has possibly occurred (91). Inference
of horizontal gene or sequence transfer by phylogenetics is
considered more sensitive and specific compared to other
approaches (92). We constructed a gene tree based on the
patatin protein domain from PLA2 (phospholipase 2) to search
for a possible HGT event that could have affected T. cruzi.
Using the PLA2 patatin domain protein sequences from the
T. cruzi Sylvio strain, we searched for similar sequences using
MEGABLAST (31) (search for highly similar sequences). We
obtained 4,354 sequences that were extracted from BLAST (21)
(Supplementary Table 6) and aligned by Muscle into Seaview
software (33). Subsequently, we generated a neighbor joining
(NJ) phylogenetic tree (Figure 2A). The NJ tree generated three
clusters with Trypanosoma species, but there was no one distant
species/taxon insertion that could be an indicator of putative
HGT. Three Trypanosoma clades, far from each other in the same
tree, occurred due to variation in the BLAST results (score and
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e-value). We also conducted a Bayesian phylogenetic inference
based on a restricted PLA2 patatin sequence alignment using
MrBayes software v.3.2 (35), which confirmed the absence of
HGT (Figure 2B).
Hypothetical Hybrid Interactome Revealed
Proteins Potentially Involved in Host
Immune Modulation
IPA (Ingenuity Pathway Analysis) was used to identify functional
and molecular networks among the list of T. cruzi and T. rangeli
PSPs and host molecules (Figures 3A,B). The analysis generated
two different networks for the PSPs of T. cruzi and T. rangeli.
The genes and gene products are represented as nodes, and the
relationships between them are represented as edges (lines). All
edges are supported by at least one literature citation or by
canonical information stored in the database. Molecules were
mapped to their corresponding node. The network generated
from the T. cruzi PSPs (represented as red nodes) showed genes
related to IL-17 production and showed central nodes including
IL-17A and NOS2 (Figure 3A). For T. rangeli, IL-15 production
FIGURE 2 | Continued
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FIGURE 2 | Patatin phospholipase domain has not been acquired by horizontal transfer (HGT). (A) Neighbor-joining (NJ) phylogenetic analysis of PLA2 patatin protein
motif sequences from several species. The phylogenetic tree was constructed using 4,354 amino acid sequences aligned by Muscle with NJ algorithm, provided with
Seaview. The branch length is proportional to amino acid differences. (a) NJ phylogenetic edited tree showing three distinct Trypanosoma species branches. SYLVIO
strain EKG05184 (used as the query in the BLAST search) is highlighted, other species are included in collapsed branches. (b) Global NJ phylogenetic tree with all
4,354 species; three Trypanosoma branches are highlighted. There were no distant species inserted in Trypanosoma branches indicating HGT. (B) Bayesian tree
constructed based on a set with 78 PLA2 patatin protein motif sequences. Node labels represent the posterior probabilities values. There were no distant species in
Trypanosoma branches indicating HGT.
was the main biological function predicted to be related to the
genes in the network (Figure 3B).
T. cruzi induces expression of proteins that trigger a decrease
in IL-17 production, while T. rangeli leads to interleukin 15
(IL-15) production, as shown in Figures 3A,B, respectively.
Although both species are parasites of mammals and are
evolutionarily related, T. rangeli infection in humans is
promptly eliminated by the host (93–96). Studies have failed to
demonstrate T. rangeli multiplication in vertebrate hosts, and
its pathogenicity and virulence are still not well-understood
(95–97). Thus, very little information is available regarding
induction of the immune response by T. rangeli since this parasite
appears to be harmless to mammals and may be eliminated
by the complement system (98). Successful immune responses
against pathogens depend upon efficient stimuli and consequent
cytokine synthesis and equilibrium (99, 100). According to IPA
analysis, T. rangeli triggers IL-15 synthesis, which is associated
with nuclear factor (NF)-kB complex activation (Figure 3B). It
has been demonstrated in cerebral epithelial cell lines that nuclear
translocation of the p65 subunit of NF-kB is one of the major
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FIGURE 3 | Hypothetical hybrid interactome revealed proteins potentially involved in host immune modulation. Gene and functional interaction networks for potential
T. cruzi (A) and T. rangeli (B) PSPs (red nodes) identified by screening for orthologous genes in human protein databases. Molecules are represented as nodes
(shaded gray), and the biological relationship between two nodes is represented as an edge (line). A line denotes binding of proteins, whereas a line with an arrow
denotes that one protein acts on another. A dotted line denotes an indirect relationship. Each node shape represents one type of molecule, as described in the figure
legend. Molecules in orange represent activation and those in blue represent inhibition. Colorless molecules indicate no prediction of interaction.
activators of IL-15 upon stimulation with TNF-α (101). IL-15
promotes B, T, and NK cell differentiation and proliferation and
also functions as a danger signal during the inflammatory process
(102, 103). Our data suggest that the inability of T. rangeli to
establish infection may be related to the activation of IL-15. IL-
15 signaling begins with the binding of IL-15 to IL15Rα on the
surface of antigen-presenting cells, triggering trans presentation
to effector cells through its heterotrimeric receptor (IL15Rα, IL-
2R/IL-15Rβ, and the typical cytokine receptor y-chain) and can
lead to activation of the immune response by diverse routes
(103). IL-15 production is commonly associated with efficient
control of blood brain barrier permeability in the extracellular
nervous system fluid which is a hardly selective semipermeable
border (101, 104, 105). Trans-activation of the IL-15 complex
is a crucial factor in protecting against cerebral injuries in
Plasmodium-infected mice through the induction of IL-10-
producing NK cells (105). Therefore, one can assume that IL-15
may enable the host immune system to limit T. rangeli capacity
for cell entry and eliminate the protozoan while it persists
in the blood.
Conversely, T. cruzi has adopted countless strategies to
manipulate the host immune response in order to survive (106,
107). During the acute phase of Chagas disease, in which the
parasite is present in the bloodstream, an effective immune
response is established to control parasite replication in the
tissues (108) Production of interferon-γ, IL-17, and specific
antibodies by NK, T, and B cells are crucial for parasite clearance.
In mice, IL-17A deficiency impaired the activation of immune
cells critical for the killing of T. cruzi, resulting in greater
susceptibility of the mice to T. cruzi infection (109).
IL-17 impairment as a result of T. cruzi infection may
represent a crucial mechanism of parasite immune evasion and
consequent cellular infection. IL-17 is a key cytokine, produced
mainly by T helper 17 cells (Th17) that promotes the recruitment
of immune cells, including neutrophils and monocytes (110).
IL-17A is required for the elimination of bacteria, fungi, and
T. cruzi; it was found to be diminished in chagasic patients
with established heart disease, especially in patients with
congestive heart failure (111). We observed that the PSP DNAJA
2 leads to downregulation of IL-17 expression during pathogen
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invasion (Figure 3A). T. cruzi DNAJA 2 shows between 50–70%
similarity to the human isoform. DNAJA 2 is related to the
downregulation of RORα, one of the key signal transducers
and activators of Th17 cells and consequent IL-17 production.
Likewise, in vivo and in vitro studies showed that the absence of
IL-17RA (IL-17 receptor)-signaling resulted in parasite-specific
CD8+ T cell apoptosis, whereas recombinant IL-17A down-
regulated the pro-apoptotic BAD protein and promoted the
survival of activated CD8+ T cells (112). Furthermore, IL-17A
production seems to serve an important immunomodulatory
protective role during human chronic Chagas disease, which
correlates to improved left ventricular function and myocardial
damage protection (111). These effects may also be observed
in benznidazole-treated individuals with increased IL-17
blood levels (113).
CONCLUSION
PSPs from both T. cruzi and T. rangeli, which are pathogenic and
non-pathogenic to humans, respectively, have been identified
through the development of an in silico secretome. A hypothetical
hybrid interactome of PSPs revealed thatT. rangeli could enhance
the production of IL-15, leading to NF-kB complex activation,
and ultimately an immune response, which could explain the
inability of T. rangeli to establish human infection. Conversely,
T. cruzi could secrete proteins that trigger a decrease in IL-17.
IL-17A is required for the elimination of bacteria, fungi, and T.
cruzi, and it is diminished in chagasic patients with established
heart disease. These results suggest that key PSPs could be used
as novel therapeutic targets to minimize the health consequences
of Chagas disease by subverting immune response-triggered by
T. cruzi infection.
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Supplementary Figure 2 | Trypanosoma cruzi Sylvio X10/1-2012 and T. rangeli
PSPs annotation. PSPs and their respective quantities found (n) in descending
order. Proteins with only n = 1 were grouped.
Supplementary Table 1 | Annotation of PSPs of both T. cruzi Sylvio and T.
rangeli. Hypothetical proteins have been annotated manually. In blue, proteins
selected to perform human interactome; in yellow protein used to phylogenetic
tree. In green, Hsp70 proteins found in both species. TR04358 is a gene of T.
rangeli genome that has not been deposited in TriTrypDB.
Supplementary Table 2 | Manual classification of T. cruzi Sylvio PSPs according
to functional categories.
Supplementary Table 3 | Manual classification of T. rangeli PSPs according to
functional categories.
Supplementary Table 4 | Quantitative and qualitative analysis by OrthoMCL.
Amount of grouped proteins found in each organism and in both species.
Supplementary Table 5 | Identification of PSPs in other T. cruzi strains,
compared to PSPs of T. cruzi Sylvio X10/1-2012. T. cruzi Sylvio (TcI) PSPs are
used as queries to find orthologs in other strains such as Dm28 (TcI), Cl Brener
Esmeraldo-like (TcVI), Cl Brener Non-Esmeraldo-like (TcVI), and TCC TcVI). A
manual BLASTP was performed using TriTrypDB, and the presence of signal
peptide (SP) and transmembrane domains (TM) has been evaluated by Interpro
domain embedded in TriTrypDB. Proteins with E-value lower than 0 (negative
value) were considered. When two or more copies of the same protein were
found, the copy with the lowest E-value was considered. SP+ = presence of
signal peptide; TM+ = presence of transmembrane helices; SP+ TM– means that
it is considered a PSP (absence of transmembrane helices and presence of signal
peptide); “–” symbol means that ortholog was not found.
Supplementary Table 6 | Sequences producing significant alignments with
Patatin sequence of T. cruzi Sylvio (TCSYLVIO_003749).
Supplementary Table 7 | Aminoacid substitutions models.
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